Bendeka 25 mg/mL
bendamustine hydrochloride · INJECTION, SOLUTION · Teva Pharmaceuticals USA, Inc.
Bendeka is a injection, solution containing bendamustine hydrochloride at 25 mg/mL, taken intravenous. Manufactured by Teva Pharmaceuticals USA, Inc..
Key Facts
- Brand Name
- Bendeka
- Generic Name
- bendamustine hydrochloride
- NDC Code (Product)
63459-348- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Strength
- 25 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA208194
- Marketing Start
- 12/08/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Bendeka used for?
Bendeka contains bendamustine hydrochloride. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Bendeka a controlled substance?
Bendeka is not classified as a controlled substance by the DEA.
What is the generic name for Bendeka?
The generic name for Bendeka is bendamustine hydrochloride. There are 11 other brand versions of bendamustine hydrochloride.
What is the NDC code for Bendeka 25 mg/mL?
The NDC (National Drug Code) for Bendeka 25 mg/mL is 63459-348, listed by Teva Pharmaceuticals USA, Inc..
Other Bendamustine Brands
See all →- bendamustine hydrochloride100 mg/20mL68001-572
- VIVIMUSTA25 mg/mL24338-270
- BELRAPZO100 mg/4mL42367-521
- BENDAMUSTINE HYDROCHLORIDE25 mg/5mL55150-391
- BENDAMUSTINE HYDROCHLORIDE100 mg/20mL55150-392
- BENDAMUSTINE HYDROCHLORIDE100 mg/4mL83831-183
- TREANDA25 mg/5mL63459-390
- bendamustine hydrochloride100 mg/20mL16729-251
- VIVIMUSTA25 mg/mL71225-120
- BENDAMUSTINE HYDROCHLORIDE100 mg/110019-079
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)